Why Arrowhead Pharmaceuticals Is Drawing Investor Attention Now Arrowhead Pharmaceuticals (ARWR) is back on many watchlists after a sharp total return over the past 3 months and the past year. This ...
This biotech firm develops RNAi therapeutics for rare and serious diseases, leveraging clinical partnerships to advance its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results